Potential of tocotrienols in the prevention and therapy of Alzheimer's disease

Medicine & Life Sciences

• Tocotrienols 99%
• farnesyl pyrophosphate 55%
• Alzheimer Disease 49%
• geranylgeranyl pyrophosphate 45%
• 3-hydroxy-3-methylglutaryl-coenzyme A 37%
• Mevalonic Acid 28%
• Oxidoreductases 26%
• Tocopherols 18%
• Sterol Regulatory Element Binding Protein 2 11%
• Protein Prenylation 10%
• Therapeutics 10%
• Prenylation 9%
• Edible Plants 9%
• Amyloidogenic Proteins 9%
• Terpenes 8%
• Hypercholesterolemia 7%
• Hydroxymethylglutaryl-CoA Reductase Inhibitors 6%
• Brain Diseases 6%
• Amyloid 6%
• Biological Availability 6%
• Anti-Inflammatory Agents 5%
• Cholesterol 5%
• Retrospective Studies 4%
• Clinical Trials 4%
• Inflammation 4%
• Incidence 3%
• Serum 3%

Chemistry

• Tocotrienol 100%
• Coenzyme A 52%
• Tocopherol 26%
• Cholesterol 19%
• Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor 15%
• Prenylation 15%
• Serum Level 14%
• Isoprenoid 13%
• Neuroprotective 13%
• Sterol 11%
• Bioavailability 10%
• Antiinflammatory 10%
• Protein 8%
• Food 7%
• Metabolite 7%
• Block Like Crystal 7%